查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363022

内分泌检测市场规模、份额和趋势分析报告：按检测类型、技术、最终用途、地区、细分趋势，2023-2030

Endocrine Testing Market Size, Share & Trends Analysis Report By Test Type (FSH, Insulin), By Technology (Tandem Mass Spectrometry, Immunoassay), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10个工作天内

价格

内分泌检测市场成长与趋势：

Grand View Research, Inc.最新报告显示，到2030年，全球内分泌检测市场规模预计将达到214.2亿美元，预测期内年复合成长率为8.4%。

成人和老年族群中肥胖、糖尿病和甲状腺等文明病的患病日益增加，推动了对内分泌检测的需求。定期对个人进行内分泌检测有助于维持整体健康，因此更好的健康意识对全球内分泌检测市场的成长做出了重大贡献。

根据世界卫生组织统计，2020年有超过3,900万五岁以下儿童超重或肥胖。久坐的生活方式和不健康的用餐选择会导致一般人群肥胖和糖尿病。此类疾病的发生促使人们对代谢功能和相关荷尔蒙失调进行了大量研究。

政府和私人组织的财政支持也激励科学界。例如，NIH 的 NIDDK（国家糖尿病、消化和肾臟疾病研究所）促进了许多资助的研究项目，旨在透过更好地了解疾病来改善健康。 NIDDK 的此类配合措施之一是 2022 年 9 月举办的大西洋中部糖尿病和肥胖研究研讨会。这使得科学知识的替换和交流成为可能，并实现区域层面的合作。这些配合措施预计将增进对人体分泌功能的了解，并进一步促进内分泌检测市场的成长。

欠低度开发国家和新兴国家缺乏认识预计将减缓内分泌检测市场的成长。不断发展的医疗环境和缺乏报销模式阻碍了这些地区的个人接受定期内分泌检查。然而，随着 COVID-19大流行期间人们对健康系统的认识增强，预计这些国家的检测频率将会增加。

COVID-19疫情为内分泌检测的应用创造了有利的机会。 COVID-19 感染会导致损害许多器官的全身性疾病。因此，这些患者存在许多代谢和荷尔蒙紊乱，导致内分泌研究的增加。例如，2021 年 3 月，内分泌学会成员核准了100 亿美元用于支持 COVID-19 研究，以识别和了解 COVID-19 对内分泌系统的短期和长期影响。同样，2020 年 9 月，美国糖尿病协会在各种研究项目中投资了 100 万美元，以调查糖尿病与 COVID-19 之间的关联。因此，需求增加并进一步推动市场成长。

此外，由于隔离而造成的行动限制和限制也鼓励了医疗咨询和家庭样本收集服务的数位平台的发展。用于在家检测荷尔蒙水平的护理点设备和套件的可用性也推动了整个内分泌检测市场的成长。

由于预计内分泌检测市场成长的各种要素，市场参与者也在扩大其区域业务。合作、伙伴关係和全球扩张是主要参与者推动产生收入的一些业务策略。例如，2022年2月，美国控股实验室公司（Labcorp）宣布在美国美国开设新实验室。印第安纳州南本德的新诊断业务将增强该公司的服务，并为该地区的患者和医生提供服务。

内分泌检测市场报告亮点

  • 依检测类型划分，2022年人类绒毛膜促性腺激素（hCG）荷尔蒙检测占最大份额。这是由于药房中存在自我检测套组，以及用于定量评估的实验室和医院检测。此外，怀孕不同周期间的检测频率和大量生育妇女也发挥了作用。
  • 从技术角度来看，免疫分析在 2022 年占据市场主导地位。这是由于主要企业的设备使用基于免疫分析的检测技术。许多依赖免疫分析技术的仪器和测试面板正在推动内分泌测试市场的成长。
  • 以最终用途，商业实验室对 2022 年的销售额贡献显着。内分泌和生殖功能多样化测试组的可行性和可用性、家庭收集等服务以及数位平台的存在正在导致细分市场份额的成长。
  • 2022年，北美将成为内分泌检测市场销售额最高的地区。这是由于美国口中甲状腺疾病、糖尿病和肥胖症的盛行率很高。此外，该地区的医疗发展和支出模式的增加也导致了收益的增加。

目录

第1章调查方法与范围

第2章执行摘要

第3章内分泌检测市场变数、趋势、范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 内分泌检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章内分泌检测：检测类型的估计与趋势分析

  • 内分泌检测市场：要点
  • 内分泌检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 雌二醇（E2）测试
  • 滤泡刺激素(FSH) 测试
  • 人类绒毛膜促性腺激素 (hCG) 荷尔蒙测试
  • 黄体激素（LH）测试
  • 硫酸去氢表雄酮（DHEAS）测试
  • 黄体酮测试
  • 睪酮测试
  • 甲状腺刺激素（TSH）测试
  • 催乳素测试
  • 皮质醇测试
  • 胰岛素测试
  • 其他的

第5章内分泌检测：技术预估与趋势分析

  • 内分泌检测市场：要点
  • 内分泌检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 串联质谱法
  • 免疫测定法
  • 单株和多株抗体技术
  • 感测器技术
  • 临床化学
  • 其他的

第6章内分泌检测：最终用途估计和趋势分析

  • 内分泌检测市场：要点
  • 内分泌检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
  • 商业实验室
  • 门诊治疗中心
  • 其他的

第7章内分泌检测市场：区域估算及趋势分析

  • 区域预测
  • 按地区分類的内分泌检测市场：市场要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott Laboratories
    • AB Sciex
    • Agilent Technologies Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • DiaSorin SpA
    • F. Hoffmann-La Roche Ltd.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Ortho Clinical Diagnostics
Product Code: 978-1-68038-862-6

Endocrine Testing Market Growth & Trends:

The global endocrine testing market size is expected to reach USD 21.42 billion by 2030, registering a CAGR of 8.4% during the forecast period, according to a new report by Grand View Research, Inc.. The growing prevalence of life style diseases such as obesity coupled with diabetes & thyroid among the adult as well as the geriatric population is driving the need for endocrine testing. The routine endocrine testing in individuals will help in overall maintenance of health and thus this awareness of better health is significantly contributing to the global endocrine testing market growth.

As per the statistics by WHO, more than 39 million children in 2020 who were under the age of 5 were overweight or obese. The sedentary life along with unhealthy diet choices have contributed to obesity as well as diabetes in the general population. This occurrence of diseased conditions has also prompted many researches into the metabolic functions and related hormonal disorders.

Funding from government and private organizations has also driven the scientific community. For instance, the NIDDK (National Institute of Diabetes and Digestive and Kidney Diseases) by NIH drives many sponsored research programs towards improving health by better understanding of diseases. One such effort by NIDDK was the mid-atlantic symposium conducted in September 2022 for diabetes and obesity research. This will enable scientific knowledge exchange and interactions and allow collaboration at the regional level. Such initiatives will drive the understanding of endocrine function in the human body and will further enable the endocrine testing market growth.

The lack of awareness in underdeveloped and developing countries is anticipated to slow the growth of endocrine testing market. The developing health care settings and absence of reimbursement models restrain the individuals in these regions to undergo routine endocrine testing. However, with the growing consciousness of a healthy system during the COVID-19 pandemic is expected to upswing the testing frequency for these countries as well.

The outbreak of COVID-19 has created lucrative opportunities for the application of endocrine testing. COVID-19 infections cause a systemic disease that injures many organs. Therefore, these patients have many metabolic and hormonal disturbances that led to an increase in the number of endocrine research. For instance, in March 2021, Endocrine society members sanctioned USD 10 billion to support COVID-19 research to identify and understand the short and long-term COVID-19 effects on the endocrine system. Similarly, in September 2020, The American Diabetes Association invested USD 1 million to fund various research projects for investigating the link between diabetes and COVID-19. Thus, it will increase the demand and further boost market growth.

In addition, the limitation of movement and restrictions due to the lockdown encouraged the digital platform for medical consultation and at home sample collection services as well. The availability of point-of-care devices and kits for the detection of hormone levels at home is also driving the overall growth of endocrine testing market.

The market players are also expanding their regional presence due to various factors that are anticipated to grow the endocrine testing market. Collaboration, partnerships and global expansions are some of the business strategies by the key players to drive revenue generation. For instance, in February 2022 Laboratory Corporation of America Holdings (Labcorp) announced opening of a new laboratory in Indiana, U.S. The new diagnostics business in South Bend, Indiana will enhance the company's services and make their offerings accessible to both patients as well as physicians in this region.

Endocrine Testing Market Report Highlights:

  • By test type, the human Chorionic Gonadotropin (hCG) hormone testing accounted for the largest share in 2022, driven by the presence of self-test kits at pharmacy stores, along with tests in laboratories or hospitals for quantitative evaluation. Moreover, the frequency of testing during different weeks of pregnancy and high number of fertile female population are also the contributing factors.
  • By technology, immunoassay dominated the 2022 market, owing to the presence of instruments by key players which uses immunoassay-based detection techniques. The large number of instruments and test panels which rely on immunoassay technology, drives the endocrine testing market growth.
  • By end-user, commercial laboratories contributed majorly to the revenue generation in 2022. The feasibility & availability of variety of testing panels for endocrinology and reproductive functions, services like at home collection and presence of digital platforms led to the increased segment share.
  • North America had the highest revenue generated in 2022 for endocrine testing market. This is attributed to the vast presence of thyroid disorders, diabetes and obesity within the US population. Additionally, developed healthcare and increased spending pattern in this region also led to higher revenue generation.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Test Type
    • 1.1.2. Technology
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Test Type outlook
    • 2.2.2. Technology outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Endocrine Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Endocrine Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Endocrine Testing: Test Type Estimates & Trend Analysis

  • 4.1. Endocrine Testing Market: Key Takeaways
  • 4.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Estradiol (E2) Test
    • 4.3.1. Estradiol (E2) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Follicle Stimulating Hormone (FSH) Test
    • 4.4.1. Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Human Chorionic Gonadotropin (hCG) Hormone Test
    • 4.5.1. Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Luteinizing Hormone (LH) Test
    • 4.6.1. Luteinizing Hormone (LH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Dehydroepiandrosterone Sulfate (DHEAS) Test
    • 4.7.1. Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.8. Progesterone Test
    • 4.8.1. Progesterone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.9. Testosterone Test
    • 4.9.1. Testosterone test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.10. Thyroid Stimulating Hormone (TSH) Test
    • 4.10.1. Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.11. Prolactin Test
    • 4.11.1. Prolactin test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.12. Cortisol Test
    • 4.12.1. Cortisol test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.13. Insulin Test
    • 4.13.1. Insulin test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.14. Others
    • 4.14.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Endocrine Testing: Technology Estimates & Trend Analysis

  • 5.1. Endocrine Testing Market: Key Takeaways
  • 5.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Tandem Mass Spectrometry
    • 5.3.1. Tandem mass spectrometry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Immunoassay
    • 5.4.1. Immunoassay market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Monoclonal & Polyclonal Antibody Technologies
    • 5.5.1. Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Sensor Technology
    • 5.6.1. Sensor technology market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Clinical Chemistry
    • 5.7.1. Clinical chemistry market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.8. Others
    • 5.8.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Endocrine Testing: End-use Estimates & Trend Analysis

  • 6.1. Endocrine Testing Market: Key Takeaways
  • 6.2. Endocrine Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Commercial Laboratories
    • 6.4.1. Commercial laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Ambulatory Care Centers
    • 6.5.1. Ambulatory care centers market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Endocrine Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Endocrine Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott Laboratories
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. AB Sciex
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Agilent Technologies Inc.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. bioMerieux SA
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Bio-Rad Laboratories Inc.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. DiaSorin S.p.A.
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. F. Hoffmann-La Roche Ltd.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Laboratory Corporation of America Holdings
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Quest Diagnostics Incorporated
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Ortho Clinical Diagnostics
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 3 North America endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 4 North America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 7 U.S. endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 8 U.S. endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 10 Canada endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 11 Canada endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 13 Europe endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 14 Europe endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 17 Germany endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 18 Germany endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 20 UK endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 21 UK endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 23 France endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 24 France endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 26 Italy endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 27 Italy endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 29 Spain endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 30 Spain endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 32 Sweden endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 33 Sweden endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 35 Norway endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 36 Norway endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 38 Denmark endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 39 Denmark endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 China endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 45 China endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 46 China endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 48 Japan endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 49 Japan endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 51 India endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 52 India endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Australia endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 54 Australia endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 55 Australia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Thailand endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 57 Thailand endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 58 Thailand endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 South Korea endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 60 South Korea endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 61 South Korea endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 63 Latin America endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 64 Latin America endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 67 Brazil endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 68 Brazil endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 70 Mexico endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 71 Mexico endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 73 Argentina endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 74 Argentina endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa endocrine testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 80 South Africa endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 81 South Africa endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 86 UAE endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 87 UAE endocrine testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait endocrine testing market, by test type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait endocrine testing market, by technology, 2018 - 2030 (USD Million)
  • Table 90 Kuwait endocrine testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Endocrine testing: Market outlook
  • Fig. 9 Endocrine testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Endocrine testing market driver impact
  • Fig. 15 Endocrine testing market restraint impact
  • Fig. 16 Endocrine testing market strategic initiatives analysis
  • Fig. 17 Endocrine testing market: Test type movement analysis
  • Fig. 18 Endocrine testing market: Test type outlook and key takeaways
  • Fig. 19 Estradiol (E2) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Follicle Stimulating Hormone (FSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Human Chorionic Gonadotropin (hCG) hormone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Luteinizing Hormone (LH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Dehydroepiandrosterone Sulfate (DHEAS) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Progesterone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Testosterone test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Thyroid Stimulating Hormone (TSH) test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Prolactin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cortisol test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 29 Insulin test market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Endocrine testing market: Technology movement analysis
  • Fig. 32 Endocrine testing market: Technology outlook and key takeaways
  • Fig. 33 Tandem mass spectrometry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Immunoassay market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Monoclonal & polyclonal antibody technologies market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Sensor technology market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Clinical chemistry market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Endocrine testing market: End-use movement analysis
  • Fig. 40 Endocrine testing market: End-use outlook and key takeaways
  • Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Commercial laboratories market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Ambulatory care centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Global endocrine testing market: Regional movement analysis
  • Fig. 46 Global endocrine testing market: Regional outlook and key takeaways
  • Fig. 47 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 73 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 74 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)